Pearce IP’s Naomi Pearce speaks to Kate Legge about the key IP strategies to enable the launch of biosimilars around the world, with a particular focus on Australia. Offering practical tips to success for biosimilar companies, this 14 minute PiPCast touches on:
- biosimilar FTO/clearance strategies, litigation, and settlement strategies;
- key lessons learned from the 11 AbbVie global royalty bearing deals relating to adalimumab (Humira®); and
- Australian biosimilar litigations.